Literature DB >> 19885557

MicroRNAs that respond to histone deacetylase inhibitor SAHA and p53 in HCT116 human colon carcinoma cells.

Sangsu Shin1, Eun-Mee Lee, Hwa Jun Cha, Seunghee Bae, Jin Hyuk Jung, Sun-Mi Lee, Youngmin Yoon, Hyunjin Lee, Sumi Kim, Hyunsook Kim, Su-Jae Lee, In-Chul Park, Young-Woo Jin, Sungkwan An.   

Abstract

MicroRNAs (miRNAs) are important post-transcriptional regulators involved in many biological processes. We investigated the expression profiles of miRNAs affected by the histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), and p53 in the human colon cancer cell line, HCT116 (wt-p53) and its derivative, HCT116 (null-p53). In a microarray assay, 144 of 275 human miRNAs showed several-fold changes in transcription. Most of these miRNAs were strongly affected by SAHA, and their expression profiles varied depending on the presence of p53. Thirty-one miRNAs showing the greatest expression changes were selected for target prediction, and genes related to apoptosis (102), cell cycle (38), and differentiation (102) were predicted. Each miRNA had many target genes, and several genes also were targeted by many miRNAs. Putative p53 upstream binding sites for the miRNAs were determined, and most sites scored >85%, suggesting a high probability of binding. In conclusion, we identified several miRNAs whose expression was affected by both SAHA and p53. Many of the miRNAs showed dramatic changes and were predicted to target many mRNAs. Further studies will be needed to verify these predictions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19885557     DOI: 10.3892/ijo_00000452

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  21 in total

1.  Neuronal differentiation by TAp73 is mediated by microRNA-34a regulation of synaptic protein targets.

Authors:  Massimiliano Agostini; Paola Tucci; Richard Killick; Eleonora Candi; Berna S Sayan; Pia Rivetti di Val Cervo; Pierluigi Nicotera; Frank McKeon; Richard A Knight; Tak W Mak; Gerry Melino
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

Review 2.  Causes and consequences of microRNA dysregulation.

Authors:  Marilena V Iorio; Carlo M Croce
Journal:  Cancer J       Date:  2012 May-Jun       Impact factor: 3.360

Review 3.  MicroRNAs, diet, and cancer: new mechanistic insights on the epigenetic actions of phytochemicals.

Authors:  Mansi A Parasramka; Emily Ho; David E Williams; Roderick H Dashwood
Journal:  Mol Carcinog       Date:  2011-07-07       Impact factor: 4.784

Review 4.  Epigenetic programming of hypoxic-ischemic encephalopathy in response to fetal hypoxia.

Authors:  Qingyi Ma; Lubo Zhang
Journal:  Prog Neurobiol       Date:  2014-11-11       Impact factor: 11.685

Review 5.  MicroRNAs as targets for dietary and pharmacological inhibitors of mutagenesis and carcinogenesis.

Authors:  Alberto Izzotti; Cristina Cartiglia; Vernon E Steele; Silvio De Flora
Journal:  Mutat Res       Date:  2012-06-07       Impact factor: 2.433

6.  The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells.

Authors:  Lyndsay V Rhodes; Ashley M Nitschke; H Chris Segar; Elizabeth C Martin; Jennifer L Driver; Steven Elliott; Seung Yoon Nam; Meng Li; Kenneth P Nephew; Matthew E Burow; Bridgette M Collins-Burow
Journal:  Oncol Rep       Date:  2011-10-04       Impact factor: 3.906

7.  A unique histone deacetylase inhibitor alters microRNA expression and signal transduction in chemoresistant ovarian cancer cells.

Authors:  Curt Balch; Kaleb Naegeli; Seungyoon Nam; Brett Ballard; Alan Hyslop; Christina Melki; Elizabeth Reilly; Man-Wook Hur; Kenneth P Nephew
Journal:  Cancer Biol Ther       Date:  2012-06-01       Impact factor: 4.742

Review 8.  microRNA involvement in human cancer.

Authors:  Marilena V Iorio; Carlo M Croce
Journal:  Carcinogenesis       Date:  2012-04-03       Impact factor: 4.944

9.  Reciprocal regulation between microRNAs and epigenetic machinery in colorectal cancer.

Authors:  Feng Wang; Yanlei Ma; Huamin Wang; Huanlong Qin
Journal:  Oncol Lett       Date:  2017-01-11       Impact factor: 2.967

10.  Cancer Epigenetics: Mechanisms and Crosstalk of a HDAC Inhibitor, Vorinostat.

Authors:  Jean Lee; Stephanie Huang R
Journal:  Chemotherapy (Los Angel)       Date:  2013-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.